Berry Street Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRRA
Berry Street Capital Management's SRRA Position: Q3 2022 in Review
Berry Street Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 150,000 shares — an estimated $8.25M sold.
Berry Street Capital Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $8.25M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- Berry Street Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Berry Street Capital Management sold 150,000 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $8.25M.
- Berry Street Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
- Berry Street Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $8.25M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on Berry Street Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.